Pilot Study of 18F-FLT PET

Stopped early · Not applicable

Conditions studied: CNS Brain Metastasis, Head and Neck Cancer, Lung Cancer, Prostate Cancer, Esophageal Cancer

In brief

Fractionated radiotherapy induces an observable change in the proliferative activity as assessed by pre-treatment and early-treatment 18F-FLT PET imaging. This study is designed to investigate 18F-FLT as a PET imaging agent for predicting treatment effectiveness in several tumors and will serve as a pilot study to a planned PO1 submission

Key facts

Study ID

NCT00585741

Run by

University of Wisconsin, Madison

People needed

15

Starts

2006-12-01

Expected to finish

2011-12-01

Last updated by the study team

2012-02-23

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Able to tolerate a PET/CT scan
• Age of 18 or older
• signed informed consent
• being considered for radiotherapy for treatment of CNS mets, Head and neck cancer, lung cancer, prostate cancer or esophageal cancer

You may not qualify if…

• Prior XRT to site being studied
• severe claustrophobia or inability to tolerate PET/CT
• unable to provide written consent
• pregnant or breastfeeding women

Where it is running

• University of Wisconsin Hospital and clinis — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.